Evaluation of the Effect and Safety of HeberFERON vs Heberon Alpha in Patients Infected with Corona Virus SARS-CoV-2 (Study ESPERANZA/HOPE): Study Protocol for a Randomized Controlled Trial.Bello-Rivero Iraldo, Gerardo Guillén, Francisco Hernández‐Bernal et al.|Research Square|2020Cited by 2
A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trialIdelsis Esquivel-Moynelo, Iraldo Bello Rivero, C Martínez-Suárez et al.|Annals of Antivirals and Antiretrovirals|2021Cited by 2
Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 InfectionHugo Nodarse-Cuní, Ileana Morales, Odalys Bravo et al.|Journal of Interferon & Cytokine Research|2024Cited by 1
Phase II randomized controlled trial to evaluate the efficacy and safety of HeberFERON versus Heberon alpha R in symptomatic or asymptomatic patients infected with the SARS-CoV-2 (Study ESPERANZA/HOPE).Bello-Rivero Iraldo, Gerardo Guillén, Francisco Hernández‐Bernal et al.|Research Square|2020Cited by 0
BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in CubaIraldo Bello Rivero, Gerardo Guillén, Tania Crombet et al.|Journal of Interferon & Cytokine Research|2023Cited by 0